Orion Biotechnology Shares In Vivo Efficacy Data on its Latest Best-in-Class Drug Candidate
Ottawa, Canada, Dec. 01, 2022 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously